Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-13-000031
Filing Date
2013-02-14
Accepted
2013-02-14 20:35:14
Documents
1
Period of Report
2013-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 15838
  Complete submission text file 0000874015-13-000031.txt   17180
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
O'NEIL PATRICK R. (Reporting) CIK: 0001564926 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 13617245